145 related articles for article (PubMed ID: 33626321)
1. PAF remodels the DREAM complex to bypass cell quiescence and promote lung tumorigenesis.
Kim MJ; Cervantes C; Jung YS; Zhang X; Zhang J; Lee SH; Jun S; Litovchick L; Wang W; Chen J; Fang B; Park JI
Mol Cell; 2021 Apr; 81(8):1698-1714.e6. PubMed ID: 33626321
[TBL] [Abstract][Full Text] [Related]
2. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
3. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
Yu C; Tian F; Liu J; Su M; Wu M; Zhu X; Qian W
Cell Prolif; 2019 May; 52(3):e12610. PubMed ID: 31012177
[TBL] [Abstract][Full Text] [Related]
6. DIAPH3 promotes the tumorigenesis of lung adenocarcinoma.
Xiang G; Weiwei H; Erji G; Haitao M
Exp Cell Res; 2019 Dec; 385(1):111662. PubMed ID: 31586548
[TBL] [Abstract][Full Text] [Related]
7. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
8. Determining the Clinical Value and Critical Pathway of GTPBP4 in Lung Adenocarcinoma Using a Bioinformatics Strategy: A Study Based on Datasets from The Cancer Genome Atlas.
Zhang Z; Wang J; Mao J; Li F; Chen W; Wang W
Biomed Res Int; 2020; 2020():5171242. PubMed ID: 33134380
[TBL] [Abstract][Full Text] [Related]
9. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
Han S; Cao D; Sha J; Zhu X; Chen D
Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
[TBL] [Abstract][Full Text] [Related]
10. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
11. NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B.
Zhang H; Wang A; Tan Y; Wang S; Ma Q; Chen X; He Z
J Cell Mol Med; 2019 Oct; 23(10):6965-6977. PubMed ID: 31448526
[TBL] [Abstract][Full Text] [Related]
12. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
[TBL] [Abstract][Full Text] [Related]
13. HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A.
Alam H; Li N; Dhar SS; Wu SJ; Lv J; Chen K; Flores ER; Baseler L; Lee MG
Cancer Res; 2018 Jul; 78(14):3834-3848. PubMed ID: 29764865
[TBL] [Abstract][Full Text] [Related]
14. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
[TBL] [Abstract][Full Text] [Related]
15.
Hu S; Zeng W; Zhang W; Xu J; Yu D; Peng J; Wei Y
Aging (Albany NY); 2020 Nov; 13(1):301-339. PubMed ID: 33231570
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
17. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
Kimura K; Matsumoto S; Harada T; Morii E; Nagatomo I; Shintani Y; Kikuchi A
Cancer Sci; 2020 Mar; 111(3):951-961. PubMed ID: 31925985
[TBL] [Abstract][Full Text] [Related]
18. DMBX1 promotes tumor proliferation and regulates cell cycle progression via repressing OTX2-mediated transcription of p21 in lung adenocarcinoma cell.
Luo J; Liu K; Yao Y; Sun Q; Zheng X; Zhu B; Zhang Q; Xu L; Shen Y; Ren B
Cancer Lett; 2019 Jul; 453():45-56. PubMed ID: 30928384
[TBL] [Abstract][Full Text] [Related]
19. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
Zhu HE; Yin JY; Chen DX; He S; Chen H
Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
[TBL] [Abstract][Full Text] [Related]
20. Methylation of CLEC14A is associated with its expression and lung adenocarcinoma progression.
Su C; Shi K; Cheng X; Han Y; Li Y; Yu D; Liu Z
J Cell Physiol; 2019 Mar; 234(3):2954-2962. PubMed ID: 30191970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]